| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥304.7B | ¥271.9B | +12.0% |
| Operating Income | ¥9.5B | ¥1.0B | +868.7% |
| Ordinary Income | ¥11.0B | ¥2.5B | +342.2% |
| Net Income | ¥9.1B | ¥68.9B | -86.7% |
| ROE | 4.0% | 31.9% | - |
FY2025 Q3 results show revenue of 304.7B yen (YoY +12.0%), operating income of 9.5B yen (YoY +868.7%), ordinary income of 11.0B yen (YoY +342.2%), and net income of 9.1B yen (YoY -86.7%). The substantial decline in net income primarily reflects the prior year comparison against 68.9B yen which included extraordinary negative goodwill of 68.2B yen from the PLASiST acquisition. Excluding this non-recurring factor, underlying profitability improved significantly with operating income rising from 1.0B yen to 9.5B yen, reflecting operational recovery across segments.
Revenue increased 32.8B yen from 271.9B yen to 304.7B yen, representing 12.0% YoY growth. The Japan segment contributed the majority of growth with revenue rising from 163.4B yen to 200.7B yen (+22.8%), while Southeast Asia revenue declined from 88.8B yen to 82.1B yen (-7.5%) and China revenue increased from 20.0B yen to 24.5B yen (+22.9%). The Japan segment revenue expansion was driven by consolidation of PLASiST, which was acquired during the prior year period and contributed incrementally to current period results.
Operating income improved dramatically from 1.0B yen to 9.5B yen, an increase of 8.5B yen. Gross profit margin stood at 16.8% (51.2B yen gross profit on 304.7B yen revenue), while SGA expenses were 41.7B yen representing 13.7% of revenue. The Japan segment returned to profitability with operating income of 8.2B yen versus a loss of 0.6B yen in the prior year, while Southeast Asia segment operating income declined from 2.6B yen to 1.1B yen, and China segment improved from a loss of 1.0B yen to profit of 0.3B yen.
Non-operating income contributed 2.7B yen including dividend income of 1.5B yen and interest income of 0.2B yen, while non-operating expenses totaled 1.3B yen including interest expense of 0.8B yen and foreign exchange losses of 0.3B yen, resulting in net non-operating income of 1.4B yen. Extraordinary items included gain on sale of assets of 0.6B yen and extraordinary losses of 0.4B yen, with minimal net impact. The prior year included negative goodwill of 68.2B yen from bargain purchase accounting for PLASiST acquisition, classified as extraordinary income but excluded from segment operating profit.
The performance pattern is revenue growth with profit expansion. The operating margin of 3.1% improved from 0.4% in the prior year but remains structurally low, indicating continued need for efficiency enhancement.
The Japan segment is the core business representing 65.8% of total revenue at 200.7B yen with operating income of 8.2B yen and margin of 4.1%. This segment drove consolidated profitability recovery, reversing from prior year operating loss through improved operational efficiency and consolidation benefits from PLASiST. The Southeast Asia segment contributed 26.9% of revenue at 82.1B yen with operating income of 1.1B yen and margin of 1.3%, showing revenue contraction and margin compression from 2.9% in the prior year, reflecting challenging regional market conditions. The China segment represented 8.0% of revenue at 24.5B yen with operating income of 0.3B yen and margin of 1.1%, achieving profitability improvement from prior year loss through revenue growth and cost management. Material margin differences exist across segments, with Japan at 4.1% significantly outperforming Southeast Asia and China both below 1.5%, indicating regional profitability disparities requiring targeted operational improvement in overseas markets.
[Profitability] ROE of 4.0% remains below the manufacturing industry median of 5.8%, while operating margin of 3.1% significantly trails the industry median of 8.9%. Net profit margin of 3.0% also underperforms the industry median of 6.5%. Gross profit margin of 16.8% indicates structural cost pressures. [Cash Quality] Cash and deposits of 55.0B yen provide coverage of 1.71 times against short-term debt of 32.1B yen, ensuring adequate liquidity. Operating cash flow data is not available for quarterly reporting, limiting assessment of earnings quality through cash conversion. [Investment Efficiency] Total asset turnover of 0.65 times exceeds the industry median of 0.56, reflecting relatively efficient asset utilization. Return on assets of 2.0% (calculated as net income 9.1B yen divided by average total assets) falls below the industry median of 3.4%. Return on invested capital remains constrained by low operating margins. [Financial Health] Equity ratio of 48.7% trails the industry median of 63.8%, indicating higher financial leverage. Current ratio of 157.9% and quick ratio of 131.6% both demonstrate healthy liquidity positions. Debt-to-equity ratio of 0.28 and interest-bearing debt of 59.1B yen represent conservative leverage levels with interest coverage ratio of 11.2 times providing ample debt service capacity.
Cash and deposits increased 12.9B yen YoY to 55.0B yen, representing 28.9% growth and strengthening liquidity position. Working capital efficiency shows mixed signals with trade receivables increasing to 115.5B yen implying receivables turnover of 138 days, significantly exceeding the industry median of 85 days and indicating collection challenges. Inventories of 44.3B yen in finished goods plus 28.1B yen in raw materials total 72.4B yen, suggesting inventory days above industry norms and potential overstocking concerns. Trade payables of 117.2B yen reflect effective supplier credit utilization. The net working capital position expanded with current assets of 266.9B yen against current liabilities of 169.1B yen, resulting in working capital of 97.8B yen. Investment securities holdings of 99.3B yen represent 21.3% of total assets, contributing dividend income but exposing the balance sheet to market valuation risk. Property, plant and equipment of 82.2B yen indicates moderate capital intensity. Cash coverage of short-term liabilities stands at 1.71 times based on cash position relative to short-term borrowings, while the broader current ratio of 157.9% confirms adequate short-term solvency despite elevated short-term debt concentration at 54.2% of total liabilities.
Ordinary income of 11.0B yen versus operating income of 9.5B yen shows net non-operating contribution of approximately 1.5B yen, comprising primarily dividend income of 1.5B yen, interest income of 0.2B yen, and other non-operating income of 1.0B yen, partially offset by interest expense of 0.8B yen and foreign exchange losses of 0.3B yen. Non-operating income represents 0.9% of revenue, consisting of recurring financial income and dividend flows from investment securities. The profit before tax of 11.2B yen reflects minimal extraordinary items in the current period with gain on asset sales of 0.6B yen and extraordinary losses of 0.4B yen netting to approximately 0.2B yen. The prior year comparison is distorted by negative goodwill of 68.2B yen from PLASiST acquisition, which inflated prior period net income to 68.9B yen. Excluding this non-recurring bargain purchase gain, year-over-year operational profit improvement is substantial. Tax expense of 2.1B yen on profit before tax of 11.2B yen implies an effective tax rate of 18.8%. Operating cash flow disclosure is unavailable in quarterly reporting, preventing direct assessment of cash-backed earnings quality, though the increase in cash position suggests positive underlying cash generation offsetting working capital expansion.
Full-year guidance projects revenue of 445.0B yen (YoY +17.3%), operating income of 12.0B yen (YoY +579.6%), ordinary income of 13.5B yen (YoY +235.4%), and net income of 9.0B yen with EPS forecast of 573.40 yen. Through Q3 representing nine months of the fiscal year, progress rates are: revenue 68.5% (304.7B of 445.0B target), operating income 79.3% (9.5B of 12.0B target), and ordinary income 81.5% (11.0B of 13.5B target). Operating income and ordinary income progress rates exceed the standard 75% threshold expected at Q3, indicating strong likelihood of achieving or exceeding full-year profit guidance. Revenue progress of 68.5% trails the 75% standard by 6.5 percentage points, suggesting Q4 revenue must accelerate to 140.3B yen representing 46.0% growth versus prior year Q4 to meet guidance, which appears aggressive given Q1-Q3 average quarterly revenue growth of 12.0%. The guidance implies Q4 operating margin improvement to approximately 1.9% if revenue target is achieved, or higher margins if revenue falls short, indicating expected continued operational leverage. Full-year dividend guidance of 120.0 yen per share represents payout ratio of approximately 20.9% based on forecast EPS of 573.40 yen, maintaining conservative distribution policy.
Annual dividend guidance stands at 120.0 yen per share consisting of year-end dividend of 100.0 yen plus interim dividend already paid. Based on forecast full-year EPS of 573.40 yen, the payout ratio is approximately 20.9%, representing conservative distribution relative to earnings. No share buyback activity is disclosed in the current period. The dividend policy reflects management's priority for balance sheet preservation and financial flexibility while providing modest shareholder returns. Total return ratio equals the payout ratio of 20.9% in the absence of buybacks. The low payout ratio combined with cash position of 55.0B yen and operating profit recovery suggests substantial capacity for dividend growth or initiation of buyback programs, though management appears to prioritize internal reinvestment and balance sheet strength given ongoing business recovery and M&A integration activities.
Operating margin compression risk persists with current operating margin of 3.1% substantially below industry median of 8.9%, indicating vulnerability to cost inflation or pricing pressure. Gross margin of 16.8% limits operating leverage, meaning revenue growth translates weakly to profit expansion. Any deterioration in pricing power or raw material cost increases could eliminate operating profitability. Working capital deterioration risk is evidenced by receivables days of 138 days versus industry median of 85 days and inventory days exceeding norms, indicating collection delays and potential inventory obsolescence exposure. The operating working capital cycle has expanded, reducing cash conversion efficiency. Continued working capital expansion would constrain free cash flow generation and potentially require additional external financing. Refinancing concentration risk exists with short-term debt representing 54.2% of total liabilities and short-term borrowings of 32.1B yen. While current cash coverage is adequate at 1.71 times, the maturity concentration creates vulnerability to credit market disruptions or banking relationship changes. The company must maintain continuous access to short-term credit facilities or generate sufficient operating cash flow to reduce short-term debt reliance.
[Industry Position] (Reference - Proprietary Analysis) Profitability metrics significantly underperform manufacturing industry medians. ROE of 4.0% trails industry median of 5.8%, ROA of 2.0% lags median of 3.4%, operating margin of 3.1% underperforms median of 8.9%, and net profit margin of 3.0% falls short of median of 6.5%. These gaps indicate structural profitability challenges requiring operational efficiency enhancement and margin expansion initiatives. Financial health shows mixed positioning with equity ratio of 48.7% below industry median of 63.8%, indicating higher leverage, though absolute debt levels remain manageable with debt-to-equity of 0.28. Current ratio of 157.9% falls below industry median of 287%, reflecting working capital intensity. Efficiency metrics show asset turnover of 0.65 times exceeding industry median of 0.56 times, demonstrating relative strength in asset utilization despite margin constraints. Growth performance with revenue growth of 12.0% significantly exceeds industry median of 2.8%, indicating market share gains or consolidation benefits, though EPS decline of 87.1% reflects prior year extraordinary items. Working capital management underperforms with receivables days of 138 versus industry median of 85 and inventory turnover trailing norms, representing key operational improvement opportunities. The company exhibits above-median growth but below-median profitability and working capital efficiency versus manufacturing sector peers.
(※ Industry: Manufacturing (N=105 companies), Comparison: FY2025 Q3, Source: Proprietary analysis)
Operational recovery is evident with operating income expanding from 1.0B yen to 9.5B yen YoY, demonstrating successful turnaround execution and PLASiST integration benefits. The Japan segment returned to profitability with 8.2B yen operating income, establishing a stable domestic earnings base. Revenue growth of 12.0% substantially outpaces industry median of 2.8%, indicating market position strengthening. However, structural profitability improvement remains incomplete as operating margin of 3.1% and ROE of 4.0% both trail industry medians by substantial margins. The gross margin of 16.8% constrains operating leverage, requiring continued focus on cost structure optimization and pricing power enhancement. Working capital efficiency deterioration presents both risk and opportunity, with receivables days of 138 significantly exceeding industry median of 85 and elevated inventory levels. Successful working capital management initiatives could unlock material cash flow improvement without revenue growth. The conservative financial profile with debt-to-equity of 0.28, interest coverage of 11.2 times, and dividend payout ratio of 20.9% provides financial flexibility for growth investment or shareholder return enhancement. The concentration of 54.2% of liabilities in short-term debt warrants monitoring of refinancing risk, though current liquidity appears adequate. Overseas segment margins of 1.1% to 1.3% lag domestic margin of 4.1%, indicating international operations require profitability improvement to justify strategic investment.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.